Short Interest in Caring Brands, Inc. (NASDAQ:CABR) Grows By 1,337.5%

Caring Brands, Inc. (NASDAQ:CABR) was the target of a significant increase in short interest during the month of August. As of August 14th, there was short interest totaling 6,138 shares, an increase of 1,337.5% from the July 30th total of 427 shares. Currently, 0.1% of the company’s shares are sold short. Based on an average daily volume of 137,498 shares, the short-interest ratio is presently 0.0 days.

Analysts Set New Price Targets

Separately, Weiss Ratings raised Caring Brands from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, June 11th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Caring Brands stock. Jane Street Group LLC purchased a new stake in Caring Brands, Inc. (NASDAQ:CABR) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 34,446 shares of the company’s stock, valued at approximately $30,000. Jane Street Group LLC owned approximately 0.25% of Caring Brands as of its most recent filing with the SEC.

Caring Brands Trading Down 4.8%

Shares of NASDAQ CABR traded down $0.07 during mid-day trading on Tuesday, reaching $1.28. The company had a trading volume of 37,511 shares, compared to its average volume of 105,325. The stock has a market cap of $13.33 million and a price-to-earnings ratio of -1.74. Caring Brands has a 52 week low of $0.71 and a 52 week high of $5.35. The business’s 50-day moving average is $1.36 and its 200-day moving average is $1.14. The company has a current ratio of 4.96, a quick ratio of 4.93 and a debt-to-equity ratio of 0.03.

Caring Brands (NASDAQ:CABR) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.10) earnings per share for the quarter.

Caring Brands Company Profile

We are a wellness consumer products company. We offer several over-the-counter, or (OTC) and cosmetic, consumer products. Our method of operation is to ensure that (1) the mechanism of action of all products is established, (2) efficacy is determined through controlled clinical trials, (3) products are protected by issued and filed patents, and (4) products have acceptable commercial stability. Prior to its Q3 2022 commercial launch in India as a treatment for vitiligo and psoriasis, Photocil was briefly launched in the United States markets from December 2022 until February 2023, however, was subsequently removed from the market due to insufficient sales resulting from the lack of a dedicated sales and marketing team.